Transitional Care Study 3

Philips Electronics Nederland B.V., acting through Research, Eindhoven,0 个研究点目标入组 350 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

暂无简介。

•Willing and able to sign informed consent form
•Willingness to abstain from visiting a sauna during the study period
•Willingness to dry area where the HealthDot is applied in a dipping fashion after washing
•Willingness to abstain from flying during the study period of time
•Elective surgery
•General anesthesia required for surgery

•General inmates of psychiatric wards, prisons, or other state institutions
•Investigator or any other team member involved directly or indirectly in the conduct of the clinical study
•Any skin condition, for example prior rash, discoloration, scars or open wounds at the area of investigation of both devices
•Pregnant, or breastfeeding
•Known to be allergic for the tissue adhesive used in the HealthDot.
•Use of topical that is known to influence the skin at the test area (such as medical and non-medical creams or lotions)
•Patient with active implantables such as Implantable Cardioverter Defibrilator (ICD) and pacemaker
•Unable to understand instructions
•Expected participation less than 2 weeks
•Left lower rib (place where HealthDot will be applied) is involved in the area of surgery, area of disinfection or area where bandages are needed.
•Area on arm where the Elan device is applied is involved in the surgical procedure.
•Patients with antibiotic resistant infections (e.g. MRSA).

发起方

Philips Electronics Nederland B.V., acting through Research, Eindhoven,